General
Preferred name
ETRETINATE
Synonyms
Retinoid ()
Tegison ()
Etretinato ()
Ethyl etrinoate ()
Ro 10-9359 ()
Tegison, Ethyl etrinoate, Retinoid, Etretinato,Ro 10-9359 ()
Tigason ()
Acitretin related compound b ()
NSC-297936 ()
RO-10-9359 ()
Ro-109359 ()
P&D ID
PD012095
CAS
54350-48-0
Tags
available
drug
Approved by
FDA
First approval
1986
Drug indication
Keratosis
psoriasis
Drug Status
approved
withdrawn
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Etretinate is a highly lipophilic second-generation retinoid. Its use has largely been discontinued as it was discovered to be a long-acting teratogen, with detectable levels in plasma up to three years post-therapy.
(GtoPdb)
PRICE
29
DESCRIPTION
Etretinate(Ro 10-9359) is a second-generation retinoid that has the potential for severe psoriasis treatment.
DESCRIPTION
Etretinate (Ro 10-9359) is an oral aromatic retinoid acid which is effective in psoriasis and other dermatological syndromes. It activates retinoid receptors, causing an induction of cell differentiation, inhibition of cell proliferation, and inhibition of tissue infiltration by inflammatory cells.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
16
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Withdrawn 2.0
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
38
Molecular Weight
354.22
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
0
Rotatable Bonds
7
Ring Count
1
Aromatic Ring Count
1
cLogP
5.65
TPSA
35.53
Fraction CSP3
0.35
Chiral centers
0.0
Largest ring
6.0
QED
0.36
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Apoptosis
RARA, RXRG
Retinoid Receptor
MOA
protein synthesis inhibitor
ATC
D05BB01
Toxicity type
reproductive
Source data

